CDC study: HPV vaccines could prevent most oropharyngeal cancers
July 23, 2014 -- Human papillomavirus (HPV) vaccines could prevent most oropharyngeal cancers in the U.S., according to a new Centers for Disease Control and Prevention (CDC) study in Emerging Infectious Diseases. The analysis of patients with oropharyngeal cancer found that most were HPV-positive, especially for HPV types 16 and 18, and the majority of patients were white men.
Advaxis, MedImmune partner on clinical trial
July 22, 2014 -- Advaxis, a biotechnology company that develops cancer immunotherapies, has entered a clinical trial collaboration with MedImmune, the biologics research and development arm of AstraZeneca.
Investigational drug may benefit head/neck cancer patients
July 14, 2014 -- The investigational drug dacomitinib may benefit patients with recurrent or metastatic squamous cell carcinoma of the head and neck, according to the results of phase II clinical trial by researchers in South Korea.
ACS awards $1.7M to study racial disparities in HNC patients
July 10, 2014 -- The American Cancer Society (ACS) has awarded a $1.7 million grant to Philadelphia researchers to investigate factors that may contribute to the racial disparities seen among those diagnosed and treated for head and neck cancers (HNC).
Study: Proton beam therapy tops IMRT for head/neck cancer
July 3, 2014 -- Proton beam therapy can provide significantly better disease-free survival and tumor control for patients with head and neck cancer than intensity-modulated radiation therapy (IMRT), according to a literature review published online June 27 in Lancet Oncology.
Genetic testing may predict aggressiveness of oral cancer
July 2, 2014 -- Genetic testing may predict the aggressiveness of oral cancer, according to a new study in Clinical Cancer Research. A highly accurate diagnostic test could alter the clinical management of oral cancer patients, according to Missouri researchers.
Salivary miRNA could provide noninvasive way to detect OSCC
June 26, 2014 -- Salivary microRNA (miRNA) could provide a noninvasive way to detect oral squamous cell carcinoma (OSCC) and perhaps monitor the disease's development in oral lichen planus patients, according to a new study in the Journal of Dental Research.
Study uncovers genetic defects in nasopharyngeal cancer
June 25, 2014 -- Singapore researchers have discovered a distinct mutational signature and nine significantly mutated genes associated with nasopharyngeal cancer, paving the way for the development of novel therapies for the disease, according to a new study in Nature Genetics.
Aspirin can help battle head/neck cancer
Aspirin appears to offer significant protection against head and neck (HNC) cancer, according to a study in the British Journal of Cancer. Regular aspirin use was associated with a 22% reduction in HNC and seems to be particularly effective in preventing laryngeal cancer.